Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Patent
1982-05-17
1984-05-29
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
424261, A61K 31725, A61K 3148
Patent
active
044514581
ABSTRACT:
The invention provides novel pharmaceutical compositions useful in the treatment of thrombosis in mammals, comprising a mixture of dihydroergotamine or a related ergot alkaloid and heparin.
REFERENCES:
Med. Klin. 70 (1975), 1553, (No. 39).
Chemical Abstracts, vol. 72, 130867k, (1970).
Deutche Med. W. 100, 2065-2069, Oct. 1975.
Bergogue-Revue de l'Atheroscleroso, (Paris), 10 (2), 11-13 (1968).
Mohe, et al.-"Sonderdruck aus der Klinik Arzt", Heft 3/75, Thrombose Prophylaxe, pp. 3-12.
Lancet, 45, 1975, pp. 45-51, 63 and 64.
Kakkar-Special Article of Circulation vol. 51, Jan. 1975, pp. 8-19.
Buhlmann Hans
Welzel Dieter
Honor Robert S.
Sandoz Ltd.
Sharkin Gerald D.
Waddell Frederick E.
LandOfFree
Method for the treatment of post-operative thrombosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of post-operative thrombosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of post-operative thrombosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1396928